Zealand Pharma A/S
ZLDPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $9 | $0 | $0 |
| % Growth | -99.5% | 112,212% | -10.6% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $9 | $0 | $0 |
| % Margin | 13.4% | 100% | 95% | 95.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | -$0 |
| SG&A Expenses | $0 | $0 | $0 | -$0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $1 | $0 | $0 |
| Operating Income | -$0 | $8 | -$0 | -$0 |
| % Margin | -145.9% | 91.7% | -5,030.1% | -4,409% |
| Other Income/Exp. Net | $0 | -$0 | $0 | $0 |
| Pre-Tax Income | -$0 | $8 | -$0 | -$0 |
| Tax Expense | $0 | $1 | -$0 | -$0 |
| Net Income | -$0 | $8 | -$0 | -$0 |
| % Margin | -127.9% | 83.3% | -4,144.1% | -3,213.7% |
| EPS | -0.9 | 107.08 | -4.75 | -4.64 |
| % Growth | -100.8% | 2,354.3% | -2.4% | – |
| EPS Diluted | -0.9 | 105.61 | -4.75 | -4.64 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | $8 | -$0 | -$0 |
| % Margin | -711.2% | 89.4% | -3,992.9% | -3,059.5% |